N@N

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 9, 2009) - Imperial Ginseng Products Ltd. (the "Company") (TSX VENTURE:IGP) today announced a proposed consolidation of its (i) common shares (the "Common Shares") and (ii) convertible preference shares, Series "A" (the "Convertible Series A Shares") (the "Consolidation").

The Common Shares will be consolidated on the basis of ten (10) existing shares for one (1) new share. Currently there are 22,153,375 Common Shares issued and outstanding. It is anticipated that the issued and outstanding Common Shares will be in the range of 2,200,000 on a post-consolidation basis.

The Convertible Series A Shares will be consolidated on the basis of twenty (20) existing shares for one (1) new share. Currently there are 26,011,622 Convertible Series A Shares issued and outstanding. It is anticipated that the issued and outstanding Convertible Series A Shares will be in the range of 1,300,000 on a post-consolidation basis.

The Board of Directors of the Company (the "Board") will ask the holders of the Common Shares at the Company's upcoming annual meeting on December 9, 2009 to approve the Consolidation. The Board will ask the holders of Convertible Series A Shares to approve the Consolidation at a separate meeting to be held in 2010. The Board may, in their sole discretion, revoke the resolution approving the Consolidation at any time prior to its implementation.

The Consolidation is subject to shareholder approval, acceptance of the TSX Venture Exchange and other regulatory approvals as may be necessary.

Further details with regard to the background of the Consolidation are contained in the Company's management proxy circular dated October 29, 2009, a copy of which is available electronically at [ www.sedar.com ].

ON BEHALF OF THE BOARD OF DIRECTORS OF IMPERIAL GINSENG PRODUCTS LTD.

Stephen McCoach, Chief Executive Officer and Director

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.